|
1
|
Zhang C, Tan Y and Xu H: Does adjuvant
chemotherapy improve the prognosis of patients after resection of
pulmonary metastasis from colorectal cancer? A systematic review
and meta-analysis. Int J Colorectal Dis. 34:1661–1671.
2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Mitry E, Guiu B, Cosconea S, Jooste V,
Faivre J and Bouvier AM: Epidemiology, management and prognosis of
colorectal cancer with lung metastases: A 30-year population-based
study. Gut. 59:1383–1388. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Labianca R, Beretta GD, Kildani B, Milesi
L, Merlin F, Mosconi S, Pessi MA, Prochilo T, Quadri A, Gatta G, et
al: Colon cancer. Crit Rev Oncol Hematol. 74:106–133.
2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tampellini M, Ottone A, Bellini E, Alabiso
I, Baratelli C, Bitossi R, Brizzi MP, Ferrero A, Sperti E, Leone F,
et al: The role of lung metastasis resection in improving outcome
of colorectal cancer patients: Results from a large retrospective
study. Oncologist. 17:1430–1438. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wang Z, Wang X, Yuan J, Zhang X, Zhou J,
Lu M, Liu D, Li J and Shen L: Survival benefit of palliative local
treatments and efficacy of different pharmacotherapies in
colorectal cancer with lung metastasis: Results from a large
retrospective study. Clin Colorectal Cancer. 17:e233–e255.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kato T, Yasui K, Hirai T, Kanemitsu Y,
Mori T, Sugihara K, Mochizuki H and Yamamoto J: Therapeutic results
for hepatic metastasis of colorectal cancer with special reference
to effectiveness of hepatectomy: Analysis of prognostic factors for
763 cases recorded at 18 institutions. Dis Colon Rectum. 46 (Suppl
10):S22–S31. 2003.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chua TC, Saxena A, Liauw W, Chu F and
Morris DL: Hepatectomy and resection of concomitant extrahepatic
disease for colorectal liver metastases-a systematic review. Eur J
Cancer. 48:1757–1765. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Koga R, Yamamoto J, Saiura A, Yamaguchi T,
Hata E and Sakamoto M: Surgical resection of pulmonary metastases
from colorectal cancer: Four favourable prognostic factors. Jpn J
Clin Oncol. 36:643–648. 2006.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Iizasa T, Suzuki M, Yoshida S, Motohashi
S, Yasufuku K, Iyoda A, Shibuya K, Hiroshima K, Nakatani Y and
Fujisawa T: Prediction of prognosis and surgical indications for
pulmonary metastasectomy from colorectal cancer. Ann Thorac Surg.
82:254–260. 2006.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kandioler D, Krömer E, Tüchler H, End A,
Müller MR, Wolner E and Eckersberger F: Long-term results after
repeated surgical removal of pulmonary metastases. Ann Thorac Surg.
65:909–912. 1998.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Regnard JF, Grunenwald D, Spaggiari L,
Girard P, Elias D, Ducreux M, Baldeyrou P and Levasseur P: Surgical
treatment of hepatic and pulmonary metastases from colorectal
cancers. Ann Thorac Surg. 66:214–218. 1998.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Okumura S, Kondo H, Tsuboi M, Nakayama H,
Asamura H, Tsuchiya R and Naruke T: Pulmonary resection for
metastatic colorectal cancer: Experiences with 159 patients. J
Thorac Cardiovasc Surg. 112:867–874. 1996.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Saito Y, Omiya H, Kohno K, Kobayashi T,
Itoi K, Teramachi M, Sasaki M, Suzuki H, Takao H and Nakade M:
Pulmonary metastasectomy for 165 patients with colorectal
carcinoma: A prognostic assessment. J Thorac Cardiovasc Surg.
124:1007–1013. 2002.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pfannschmidt J, Dienemann H and Hoffmann
H: Surgical resection of pulmonary metastases from colorectal
cancer: A systematic review of published series. Ann Thorac Surg.
84:324–338. 2007.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Nakajima J: Pulmonary metastasis:
Rationale for local treatments and techniques. Gen Thorac
Cardiovasc Surg. 58:445–451. 2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Shiomi K, Naito M, Sato T, Nakamura T,
Nakashima H, Naito M, Mikubo M, Matsui Y, Watanabe M and Satoh Y:
Effect of adjuvant chemotherapy after pulmonary metastasectomy on
the prognosis of colorectal cancer. Ann Med Surg (Lond). 20:19–25.
2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Menna C, Berardi G, Tierno SM, Andreetti
C, Maurizi G, Ciccone AM, D'Andrilli A, Cassiano F, Poggi C, Diso
D, et al: Do repeated operations for recurrent colorectal lung
metastases result in improved survival? Ann Thorac Surg.
106:421–427. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Department of Health and Human Services,
National Institutes of Health, National Cancer Institute. Common
terminology criteria for adverse events (CTCAE) v5.0 2017.
Available from: https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.pdf.
|
|
20
|
Hirosawa T, Itabashi M, Ohnuki T,
Yamaguchi N, Sugihara K and Kameoka S: Prognostic factors in
patients undergoing complete resection of pulmonary metastases of
colorectal cancer: A multi-institutional cumulative follow-up
study. Surg Today. 43:494–499. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
TNM Classification of Malignant Tumours.
8th edition. Brierley JD, Gospodarowicz MK and Wittekind C (eds.).
John Wiley & Sons, Ltd., New Jersey, 2017.
|
|
22
|
Lin BR, Chang TC, Lee YC, Lee PH, Chang KJ
and Liang JT: Pulmonary resection for colorectal cancer metastases:
Duration between cancer onset and lung metastasis as an important
prognostic factor. Ann Surg Oncol. 16:1026–1032. 2009.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Iida T, Nomori H, Shiba M, Nakajima J,
Okumura S, Horio H, Matsuguma H, Ikeda N, Yoshino I, Ozeki Y, et
al: Prognostic factors after pulmonary metastasectomy for
colorectal cancer and rationale for determining surgical
indications: A retrospective analysis. Ann Surg. 257:1059–1064.
2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gonzalez M and Gervaz P: Risk factors for
survival after lung metastasectomy in colorectal cancer patients:
Systematic review and meta-analysis. Future Oncol. 11 (2
Suppl):S31–S33. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Watanabe K, Nagai K, Kobayashi A, Sugito M
and Saito N: Factors influencing survival after complete resection
of pulmonary metastases from colorectal cancer. Br J Surg.
96:1058–1065. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Okazaki Y, Shibutani M, Wang EN, Nagahara
H, Fukuoka T, Iseki Y, Kashiwagi S, Tanaka H, Maeda K, Hirakawa K
and Ohira M: Prognostic significance of the immunological indices
in patients who underwent complete resection of pulmonary
metastases of colorectal cancer. In vivo. 35:1091–1100.
2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
An X, Ding PR, Li YH, Wang FH, Shi YX,
Wang ZQ, He YJ, Xu RH and Jiang WQ: Elevated neutrophil to
lymphocyte ratio predicts survival in advanced pancreatic cancer.
Biomarkers. 15:516–522. 2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chiang SF, Hung HY, Tang R, Changchien CR,
Chen JS, You YT, Chiang JM and Lin JR: Can neutrophil-to-lymphocyte
ratio predict the survival of colorectal cancer patients who have
received curative surgery electively? Int J Colorectal Dis.
27:1347–1357. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Mallappa S, Sinha A, Gupta S and Chadwick
SJ: Preoperative neutrophil to lymphocyte ratio >5 is a
prognostic factor for recurrent colorectal cancer. Colorectal Dis.
15:323–328. 2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hendry S, Salgado R, Gevaert T, Russell
PA, John T, Thapa B, Christie M, van de Vijver K, Estrada MV,
Gonzalez-Ericsson PI, et al: Assessing tumor-infiltrating
lymphocytes in solid tumors: A practical review for pathologists
and proposal for a standardized method from the International
immunooncology biomarkers working group: Part 1: Assessing the host
immune response, TILs in invasive breast carcinoma and ductal
carcinoma in situ, metastatic tumor deposits and areas for further
research. Adv Anat Pathol. 24:235–251. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Hendry S, Salgado R, Gevaert T, Russell
PA, John T, Thapa B, Christie M, van de Vijver K, Estrada MV,
Gonzalez-Ericsson PI, et al: Assessing tumor-infiltrating
lymphocytes in solid tumors: A practical review for pathologists
and proposal for a standardized method from the International
immuno-oncology biomarkers working group: Part 2: TILs in melanoma,
gastrointestinal tract carcinomas, non-small cell lung carcinoma
and mesothelioma, endometrial and ovarian carcinomas, squamous cell
carcinoma of the head and neck, genitourinary carcinomas, and
primary brain tumors. Adv Anat Pathol. 24:311–335. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Imanishi M, Yamamoto Y, Hamano Y, Yamada
T, Moriwaki T, Gosho M, Okumura T, Boku N, Kondo H and Hyodo I:
Efficacy of adjuvant chemotherapy after resection of pulmonary
metastasis from colorectal cancer: A propensity score-matched
analysis. Eur J Cancer. 106:69–77. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Park S, Kang BW, Lee SJ, Yoon S, Chae YS,
Kim JG, Lee KH, Koh SA, Song HS, Park KU, et al: Clinical
significance of systemic chemotherapy after curative resection of
metachronous pulmonary metastases from colorectal cancer. Cancer
Chemother Pharmacol. 80:187–193. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Sakamoto J, Kodaira S, Hamada C, Ito K,
Maehara Y, Takagi H, Sugimachi K, Nakazato H and Ohashi Y:
Meta-analysis group of the Japanese society of strategies for
Cancer Research and Therapy. An individual patient data
meta-analysis of long supported adjuvant chemotherapy with oral
carmofur in patients with curatively resected colorectal cancer.
Oncol Rep. 8:697–703. 2001.PubMed/NCBI
|
|
35
|
Hasegawa K, Saiura A, Takayama T, Miyagawa
S, Yamamoto J, Ijichi M, Teruya M, Yoshimi F, Kawasaki S, Koyama H,
et al: Adjuvant oral uracil-tegafur with leucovorin for colorectal
cancer liver metastases: A randomized controlled trial. PLoS One.
11(e0162400)2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Okumura T, Boku N, Hishida T, Ohde Y,
Sakao Y, Yoshiya K, Higashiyama M, Hyodo I, Mori K and Kondo H:
Surgical Outcome and prognostic stratification for pulmonary
metastasis from colorectal cancer. Ann Thorac Surg. 104:979–987.
2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Shibutani M, Nagahara H, Fukuoka T, Iseki
Y, Hirakawa K and Ohira M: Efficacy of adjuvant chemotherapy
according to the classification of recurrence risk based on
systemic inflammatory markers in patients with liver metastases of
colorectal cancer. Anticancer Res. 39:5039–5045. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Mantovani C, Levra NG, Filippi AR, Novello
S, Buffoni L, Ragona R and Ricardi U: Postoperative radiotherapy
for patients with completely resected pathologic n2 non-small-cell
lung cancer: A retrospective analysis. Clin Lung Cancer.
14:194–199. 2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Chiang AC and Massagué J: Molecular basis
of metastasis. N Engl J Med. 359:2814–2823. 2008.PubMed/NCBI View Article : Google Scholar
|
